Methadone and buprenorphine reduce risk of death after opioid overdose
Courtesy of NIDA A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid [...]
Special journal issue highlights ABCD brain study
A special issue of the journal Developmental Cognitive Neuroscience features more than a dozen articles related to the Adolescent Brain Cognitive Development (ABCD) Study, a [...]
WGAN = Recovery Workforce Job Fair
Recovery Workforce Job Fair June 3, 2018 | WGAN Radio Recovery Workforce Job Fair Interview with Marty Grohman, Sheriff Bill King, Jason [...]
Westbrook Addiction Treatment | Program Now Open
Westbrook Addiction Treatment now available. Welcome to our new offices in Westbrook Maine. The Westbrook office provides outpatient addiction treatment for substance use disorders [...]
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications
NIDA Press Office301-443-6245media@nida.nih.gov About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of [...]
Full survey of annual teen drug use now available with additional data
Courtesy of University of Michigan The complete volume of the 2017 Monitoring the Future Survey (MTF) teen drug use and behavior survey results is now [...]
Higher rate of substance use among Native American youth on reservations
Courtesy of NIDA A survey comparing drug use among Native American youth living on or near reservations to a national sample of American youth found [...]
Job fair to be held geared toward those in recovery
Job fair to be held geared toward those in recovery Legislative Lowdown by Rep. Martin Grohman As regular readers know, I have [...]
Method to identify undetected drug suicides wins top NIDA Addiction Science Award
A project that identified and tested a bioinformatics program that can help identify underreported suicides linked to drug overdoses was awarded the first-place distinction at [...]
FDA approves first medication to reduce opioid withdrawal symptoms
Courtesy of US WorldMeds, LLC. The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that lofexidine, [...]